✦ LIBER ✦

Aromatase expression and outcomes in the P024 neoadjuvant endocrine therapy trial

✍ Scribed by Matthew J. Ellis; William R. Miller; Yu Tao; Dean B. Evans; Hilary A. Chaudri Ross; Yasuhiro Miki; Takashi Suzuki; Hironobu Sasano

Publisher: Springer US
Year: 2008
Tongue: English
Weight: 283 KB
Volume: 116
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-008-0161-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Estrogen regulated gene expression in re

Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor

✍ Djuana M. E. Harvell; Jennifer K. Richer; Meenakshi Singh; Nicole Spoelstra; Chr 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 581 KB

Expression of epithelial–mesenchymal tra

Expression of epithelial–mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

✍ Michal Mego; Sendurai A. Mani; Bang-Ning Lee; Changping Li; Kurt W. Evans; Evan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 392 KB

## Abstract Epithelial cancer cells are likely to undergo epithelial–mesenchymal transition (EMT) prior to entering the peripheral circulation. By undergoing EMT, circulating tumor cells (CTCs) lose epithelial markers and may escape detection by conventional methods. Therefore, we conducted a pilot

The predictive value of vascular endothe

The predictive value of vascular endothelial growth factor and Ki-67 expression on neoadjuvant therapy in rectal cancer

✍ Shumei Jiang; Renben Wang; Jinming Yu; Zhenjiang Zhang; Dianbin Mu; Zhongfa Xu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 289 KB

New aromatase inhibitors as second-line

New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma : A pooled analysis of the randomized trials

✍ Paolo Carlini; Emilio Bria; Diana Giannarelli; Gianluigi Ferretti; Alessandra Fe 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

Duration of letrozole treatment and outc

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

✍ James N. Ingle; Dongsheng Tu; Joseph L. Pater; Silvana Martino; Nicholas J. Robe 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 223 KB

Impact of chemotherapy regimens prior to

Impact of chemotherapy regimens prior to endocrine therapy : Results from the ATAC (Anastrozole and Tamoxifen, Alone or in Combination) trial

✍ Aman U. Buzdar; Jean-Paul Guastalla; Jean-Marc Nabholtz; Jack Cuzick; on behalf 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB